Zhe Jiang Dayang Biotech Group Co., Ltd. (SHE:003017)
China · Delayed Price · Currency is CNY 20.24
+0.63 (3.21%)
Jul 27, 2026, 3:04 PM CST
SHE:003017 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,075 | 1,045 | 909.96 | 919.45 | 1,058 | 783.21 |
Revenue Growth | 11.46% | 14.89% | -1.03% | -13.10% | 35.10% | 15.46% |
Gross Profit Gross Profit Growth | 243.4 | 235.81 | 171.24 | 161.58 | 144.49 | 149.95 |
Operating Income Operating Income Growth | 114.85 | 111.54 | 73.5 | 56.06 | 50.41 | 66.3 |
Net Income Net Income Growth | 101.38 | 99.85 | 63.75 | 50.01 | 80.73 | 70.01 |
Earnings Per Share EPS Growth | 1.03 | 1.01 | 0.65 | 0.52 | 0.82 | 0.69 |
EPS Growth | 32.76% | 56.17% | 25.44% | -37.43% | 18.79% | -39.55% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Chemical Products Chemical Products Growth | 978.83 | 851.29 | 862.47 | 1,004 | 741.35 |
Others Others Growth | 66.61 | 58.67 | 56.98 | 53.68 | 41.86 |
Total Total Growth | 1,045 | 909.96 | 919.45 | 1,058 | 783.21 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 461.56 | 460.04 | 394.44 | 382.37 | 427.59 | 411.65 |
Total Debt Total Debt Growth | 406.99 | 366.9 | 367.56 | 250.37 | 282.14 | 179.74 |
Net Cash (Debt) Net Cash Growth | 54.58 | 93.14 | 26.87 | 132 | 145.45 | 231.91 |
Net Cash Growth | 10.15% | 246.57% | -79.64% | -9.25% | -37.28% | -40.47% |
Net Cash Per Share Net Cash Per Share Growth | 0.55 | 0.94 | 0.27 | 1.36 | 1.49 | 2.30 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 114.3 | 160.11 | 66.19 | 182.42 | 91.89 | -35.16 |
Capital Expenditures CapEx Growth | -102.95 | -76.38 | -63.45 | -103.63 | -104.65 | -93.43 |
Free Cash Flow Free Cash Flow Growth | 11.35 | 83.72 | 2.74 | 78.8 | -12.76 | -128.59 |
Free Cash Flow Growth | -79.86% | 2950.92% | -96.52% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 22.65% | 22.56% | 18.82% | 17.57% | 13.66% | 19.14% |
Operating Margin | 10.69% | 10.67% | 8.08% | 6.10% | 4.76% | 8.47% |
Pretax Margin | 10.30% | 10.22% | 7.87% | 5.11% | 5.43% | 9.72% |
Profit Margin | 9.43% | 9.55% | 7.00% | 5.44% | 7.63% | 8.94% |
FCF Margin | 1.06% | 8.01% | 0.30% | 8.57% | -1.21% | -16.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 0.250 | 0.613 | 0.119 | 0.357 |
Dividend Per Share Growth | 120.00% | 100.00% | -59.24% | 414.94% | -66.65% | 0% |
Dividend Yield | 2.55% | 2.03% | 1.67% | 3.22% | 0.78% | 1.59% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.08 | 24.82 | 23.80 | 38.95 | 20.39 | 35.82 |
P/FCF Ratio | 172.09 | 29.61 | 552.98 | 24.72 | - | - |
PS Ratio | 1.82 | 2.37 | 1.67 | 2.12 | 1.56 | 3.20 |